Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 16;14(1):230.
doi: 10.1186/s13014-019-1437-3.

Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy

Affiliations

Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy

Xiao-Juan Lv et al. Radiat Oncol. .

Abstract

Background and purpose: How to protect the ovarian function during radiotherapy is uncertain. The purpose of this study was to explore the association between the location of the transposed ovary and the ovarian dose in patients with cervical cancer received radical hysterectomy, ovarian transposition, and postoperative pelvic radiotherapy.

Methods: A retrospective analysis was conducted of 150 young patients with cervical cancer who received radical hysterectomy, intraoperative ovarian transposition, and postoperative adjuvant radiotherapy in Zhejiang Cancer Hospital. Association between location of the transposed ovaries and ovarian dose was evaluated. The transposed position of ovaries with a satisfactory dose was explored using a receiver operator characteristic curve (ROC) analysis. Patients' ovarian function was followed up 3 months and 1 year after radiotherapy.

Results: A total of 32/214 (15%) transposed ovaries were higher than the upper boundary of the planning target volume (PTV). The optimum cutoff value of > 1.12 cm above the iliac crest plane was significantly associated with ovaries above the upper PTV boundary. When the ovaries were below the upper boundary of PTV, the optimum cutoff value of transverse distance > 3.265 cm between the ovary and PTV was significantly associated with ovarian max dose (Dmax) ≤ 4Gy, and the optimum cutoff value of transverse distance > 2.391 cm was significantly associated with ovarian Dmax≤5Gy. A total of 77 patients had received complete follow-up, and 56 patients (72.7%) showed preserved ovarian function 1 year after radiotherapy, which was significantly increased compared with 3 months (44.2%) after radiotherapy.

Conclusions: The location of transposed ovaries in patients with cervical cancer is significantly correlated with ovarian dose in adjuvant radiotherapy. We recommend transposition of ovaries > 1.12 cm higher than the iliac crest plane to obtain ovarian location above PTV. When the transposed ovary is below the upper boundary of PTV, ovarian Dmax ≤4Gy may be obtained when the transverse distance between the ovary and PTV was > 3.265 cm, and the ovarian Dmax≤5Gy may be obtained when the transverse distance was > 2.391 cm.

Keywords: Dose limit; Ovarian function; Ovarian transposition; Pelvic radiotherapy; Uterine cervical neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Relationship between ovary position and PTV. a Lower boundary of the ovary is above the upper boundary of the PTV. b Lower boundary of the ovary is below the upper boundary of the PTV
Fig. 2
Fig. 2
ROC curve of the distance between the ovary and iliac crest plane to predict ovary above PTV. The AUC was 0.899 (95% CI: 0.853–0.946, p = 0.000), and the optimal cut-off point value was 1.12 cm
Fig. 3
Fig. 3
ROC curve of the distance between the ovary and PTV to predict the ovarian Dmax ≤400 cGy. The AUC was 0.779 (95% CI: 0.703–0.856, p = 0.000), and the optimal cut-off point value was 3.265 cm
Fig. 4
Fig. 4
ROC curve of the distance between the ovary and PTV to predict the ovarian Dmax ≤500 cGy. The AUC was 0.755 (95% CI: 0.638–0.872, p = 0.000), and the optimal cut-off point value was 2.391 cm
Fig. 5
Fig. 5
Sex hormone levels at different times points pre- and post-radiotherapy. The E2 levels were significantly decreased 3 months post-radiotherapy, but rebounded one-year post-radiotherapy. The FSH and LH levels were opposite trends

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015;136(8):1921–1930. doi: 10.1002/ijc.29227. - DOI - PubMed
    1. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26:555–562. doi: 10.3109/09513590.2010.488773. - DOI - PubMed
    1. Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res. 2014;7:69. doi: 10.1186/1757-2215-7-69. - DOI - PMC - PubMed
    1. Xie X, Song K, Cui B, Jiang J, Yang X, Kong B. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer. Int J Clin Oncol. 2018;23(3):522–531. doi: 10.1007/s10147-017-1225-8. - DOI - PubMed

MeSH terms